Clinical Trial Update: Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox

View source ↗

Summary

A completed non-interventional study in bipolar disorder and schizophrenia assessing Zeldox (ziprasidone) by Pfizer/Mylan Viatris; results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Zeldox (ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Bipolar Disorder, Schizophrenia | Status: COMPLETED | Results posted: 2009-08-19